Hepatocellular Carcinoma (HCC) Clinical Trials in Seoul
8 recruitingSeoul, South Korea
Showing 1–8 of 8 trials
Recruiting
Not Applicable
Scout Dose of Resin Microspheres
Hepatocellular Carcinoma (HCC)Radioembolization
Seoul National University Hospital30 enrolled1 locationNCT07476651
Recruiting
Same-day Radioembolization for Large HCC
Hepatocellular Carcinoma (HCC)
Seoul National University Hospital138 enrolled4 locationsNCT06944483
Recruiting
Streamlining Radioembolization for Small HCC
Hepatocellular Carcinoma (HCC)
Seoul National University Hospital146 enrolled4 locationsNCT06979219
Recruiting
Phase 2
A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion
Advanced Hepatocellular Carcinoma (HCC)
National Cancer Center, Korea128 enrolled2 locationsNCT06828380
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Rznomics, Inc.45 enrolled9 locationsNCT06695026
Recruiting
Phase 2
Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria
Hepatocellular Carcinoma (HCC)Radioembolization
Seoul National University Hospital100 enrolled4 locationsNCT06773845
Recruiting
Phase 1Phase 2
Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma (HCC)
Yoon Jun Kim24 enrolled1 locationNCT06911255
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+3 more
GI Innovation, Inc.358 enrolled11 locationsNCT05824975